BBDC vs BHRB

The Advanced Deterministic Scorecard reveals significant concerns, with a Piotroski F-Score of just 2/9 indicating weak financial health. Despite a high dividend yield of 11.27%, the unsustainable 108.33% payout ratio and bearish insider activity raise red flags. While profitability metrics like operating margin and ROE are strong relative to peers, elevated debt (D/E of 1.39) and deteriorating earnings momentum in recent quarters undermine confidence. The stock trades below intrinsic value estimates ($17.34) and slightly above the Graham Number ($15.40), but structural risks outweigh valuation appeal.

BHRB presents a stark contrast between deep value and deteriorating fundamental health. While the stock trades significantly below its Graham Number ($98.78) and Intrinsic Value ($227.74) with a low P/E of 8.35, the Piotroski F-Score of 3/9 indicates weak financial health. Strong earnings growth (51.8% YoY) and a consistent track record of beating estimates are offset by a bearish technical trend and a lack of dividend support. The valuation is highly attractive, but the low health score necessitates a cautious approach.